Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in Germany
The overall population-based HPV prevalence was relatively high. An important share of prevalent HR-HPV infections constituted types not covered by current HPV vaccines. With the advent of HPV screening and younger vaccinated cohorts joining screening, HPV types should be monitored closely, also in older women who were not eligible for HPV vaccination.
Authors
- Kathrin Radde
- Ulrike Bussas
- Stefanie J. Klug (ORCID: https://orcid.org/0000-0003-3523-1362)
- Chris J.L.M. Meijer (ORCID: https://orcid.org/0000-0002-2758-9463)
- Daniëlle A.M. Heideman (ORCID: https://orcid.org/0000-0001-6463-7391)
- Hans Ikenberg (ORCID: https://orcid.org/0000-0003-4381-5675)
- Luana Fiengo Tanaka (ORCID: https://orcid.org/0000-0002-2086-7491)
- Linda Liang (ORCID: https://orcid.org/0000-0003-1417-8590)
- M. Blettner
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- German Cancer Research Center (DE)
- Johannes Gutenberg University Mainz (DE)
- Heidelberg University (DE)
- Dutch Cancer Society (NL)
- University Hospital Heidelberg (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- National Center for Tumor Diseases (DE)
- Cardiovascular Center Frankfurt (DE)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1186/s12879-024-09827-7
- Citations
- 8
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 3.09
Funders
- Amsterdam University Medical Centers
- Vrije Universiteit Amsterdam
- Technische Universität München